MassBio CEO & President Kendalle Burlin O’Connell originally posted this update to LinkedIn.
Washington is clearing its desk before August recess. The Senate has stacked a final round of hearings, including several in the biotech space, the SEC sent Congress its annual capital formation recommendations, and the administration proposed new federal rules governing high-risk life sciences research.
Senate Schedules a Pre-Recess Run of Relevant Hearings: Before departing for August recess, the Senate will hold several hearings with a focus on the biotech industry. The Senate Finance Subcommittee on Health Care meets Tuesday, August 4 at 10:00 a.m. on Building a Resilient Health Care Future with Biotechnology, with witnesses including Alan Palkowitz of the Indiana Biosciences Research Institute, Kevin Outterson of Boston University, Vera Luther of Dartmouth Health, and NSCEB Vice Chair Michelle Rozo. The Senate Judiciary Committee follows the same morning at 10:15 a.m. with…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
